Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Moodys
Express Scripts
Baxter
McKesson

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Litigation Details for Rite Aid Corporation v. Medicis Pharmaceutical Corp. (M.D. Penn. 2015)

See Plans and Pricing

« Back to Dashboard

Rite Aid Corporation v. Medicis Pharmaceutical Corp. (M.D. Penn. 2015)

Docket   Start Trial Date Filed 2015-04-06
Court District Court, M.D. Pennsylvania Date Terminated
Cause 15:1 Antitrust Litigation Assigned To Yvette Kane
Jury Demand Plaintiff Referred To
Parties MEDICIS PHARMACEUTICAL CORP.; RITE AID CORPORATION; RITE AID HDQTRS. CORP.
Patents 5,908,838; 7,541,347; 7,544,373; 7,790,705; 7,919,483; 8,268,804
Attorneys Barry L. Refsin; Monica L. Rebuck
Firms Hangley Aronchick Segal Pudlin and Schiller; Hangley Aronchick Segal Pudlin Schiller
Link to Docket External link to docket
Small Molecule Drugs cited in Rite Aid Corporation v. Medicis Pharmaceutical Corp.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Rite Aid Corporation v. Medicis Pharmaceutical Corp. (M.D. Penn. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-04-06 1 three years it was marketed), U.S. Patent No. 5,908,838 (the “‘838 Patent”), was likely invalid and/or unenforceable…838 and ‘705 patents (and certain other “patent rights” including other patents and patent applications…the ‘838 Patent on December 3, 2008. 57. U.S. Patent No. 7,541,347 (the “‘347 Patent”) was …The ‘347 Patent expires in 2027. 58. U.S. Patent No. 7,544,373 (the “‘373 Patent”) was issued…The ‘483 Patent expires in 2027. 61. U.S. Patent No. 8,268,804 (the “‘804 Patent”) was issued External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Harvard Business School
Medtronic
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.